FDMT Tingkat bathi resik 4D Molecular Therapeutics Inc

4DMT (FDMT) - logo korporat

The prospects for 4D Molecular Therapeutics (FDMT) depend on the safety of gene vectors and the success of ophthalmology drug trials. The company's commercial profit margin reflects profitability dynamics, where -208.60 indicates the current level. Anticipation of data regarding eye disease therapies is fueling speculative demand. Overall, the business relies on a precision gene delivery platform for the treatment of rare pathologies.

FDMT Margin dodolan resik 4D Molecular Therapeutics (04.07.2022 - 20.11.2026)

Rincian metrik keuangan lan pasar 4D Molecular Corp (FDMT)

- rega pasar lan target rega analis:
Analisis wiwitan perusahaan:4D Molecular Therapeutics, Inc. - FDMT
Produk merek 4D Molecular Therapeutics Inc

The stability of the US jurisdiction and the humanitarian status of gene therapy developments minimize external risks for 4D Molecular Therapeutics (FDMT). An analysis of the net margin allows for an assessment of the net profit share relative to total revenue, revealing the actual efficiency of cost management and the balance of the business model, which helps investors avoid overpaying for the asset during periods of market volatility.

Pesaing langsung

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|LXEO: Margin resik|KRRO (Korro Bio, Inc) - Rentabilitas dodolan miturut bathi resik|Editas Medicine (EDIT) - Margin dodolan resik|Margin resik Silence Therapeutics Inc.|Rentabilitas dodolan resik PRQR (proqr.com)|Margin resik Codexis Bio (CDXS)|Margin dodolan resik sangamo.com (SGMO)|Margin resik nautilus.bio NAUT|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX